AGM
STLN

Alpine Global Management’s Starling Oncology STLN Stock Holding History

Alpine Global Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-46,326
Closed -$76K – 398
2022
Q4 		$76K Buy
+46,326
New +$130K 0.03% 366
2022
Q2 		– Sell
-40,951
Closed -$292K – 636
2022
Q1 		$292K Sell
40,951
-344,037
-89% -$2.32M 0.07% 186
2021
Q4 		$3.75M Buy
+384,988
New +$3.42M 0.55% 34
2020
Q4 		– Sell
-64,081
Closed -$664K – 298
2020
Q3 		$664K Buy
+64,081
New +$666K 0.14% 98

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Alpine Global Management's STLN Position: Q1 2023 in Review

Alpine Global Management sold out of Starling Oncology (STLN) in Q1 2023, closing a stake of 46,326 shares — an estimated $76K sold.

Alpine Global Management first reported a position in STLN in Q3 2020 and held it in 4 quarters. The position peaked at $3.75M in Q4 2021. 39 funds tracked by Wall St. Rank hold STLN as of Q1 2023.

  • Alpine Global Management reported no remaining Starling Oncology position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 46,326 Starling Oncology shares in Q1 2023, an estimated $76K.
  • Alpine Global Management first reported a position in Starling Oncology in Q3 2020 and held it in 4 quarters.
  • Alpine Global Management's Starling Oncology position peaked at $3.75M in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Starling Oncology as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.